Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors
Yongfang Yao, Tao Huang, Yuyang Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 652-665
Open Access | Times Cited: 16

Showing 16 citing articles:

Anti-angiogenic and anti-oxidant effects of 2-NTI indole derivative vs. suramin in ex vivo, in vivo, and in vitro studies
Bayan Jamal Khaleel, H. Salman, Haitham Mahmood Kadhim, et al.
Cytotechnology (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 3
Inhibitory effects of carbohydrazide indole derivative on micro-blood vessel growth using ex vivo, in vivo, and in vitro assays
Bayan Jamal Khaleel, H. Salman, Haitham Mahmood Kadhim, et al.
In Vitro Cellular & Developmental Biology - Animal (2025)
Closed Access
Rational design, synthesis and biological evaluation of novel 2-(substituted amino)-[1,2,4]triazolo[1,5-a]pyrimidines as novel tubulin polymerization inhibitors
Lin Chen, Tangyang Ji, Xian‐Sen Huo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114864-114864
Closed Access | Times Cited: 21
Design, Synthesis, and Evaluation of Novel Indole Hybrid Chalcones and Their Anticancer and Antioxidant Activity
Z Kudlicková, Radka Michalková, Aneta Salayová, et al.
(2023)
Open Access | Times Cited: 7
Design, Synthesis, and Evaluation of Novel Indole Hybrid Chalcones and Their Antiproliferative and Antioxidant Activity
Z Kudlicková, Radka Michalková, Aneta Salayová, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6583-6583
Open Access | Times Cited: 7
Indole derivatives targeting colchicine binding site as potential anticancer agents
Bharat Goel, Shivani Jaiswal, Shreyans K. Jain
Archiv der Pharmazie (2023) Vol. 356, Iss. 10
Closed Access | Times Cited: 5
Recent advances in the green synthesis of indole and its derivatives using microwave irradiation and the role of indole moiety in cancer
Faisal A. Almalki, Alaa O. Baryyan
Green Chemistry Letters and Reviews (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Antiangiogenic activity of 5-bromoindole carbothioamide derivative in ex vivo, in vivo, and in vitro experimental study
Zainab M. Ali, Haitham Mahmood Kadhim, Omeed M. Hassan, et al.
Pharmacia (2024) Vol. 71, pp. 1-9
Open Access | Times Cited: 1
Tubulin-Targeted Therapy in Melanoma Increases the Cell Migration Potential by Activation of the Actomyosin Cytoskeleton─An In Vitro Study
Marcin Luty, Renata Szydlak, Joanna Pabijan, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 11, pp. 7155-7166
Open Access | Times Cited: 1
Discovery of a novel piperlongumine analogue as a microtubule polymerization inhibitor with potent anti-angiogenic and anti-metastatic efficacy
Jinling Qin, LI Hong-liang, Xuan Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114738-114738
Closed Access | Times Cited: 8
Discovery of N-(2-oxoethyl) sulfanilamide-derived inhibitors of KAT6A (MOZ) against leukemia by an isostere strategy
Yongtao Duan, Yabiao Zhao, Zhenzhen Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115770-115770
Closed Access | Times Cited: 2
Interaction of norsecurinine-type monomeric and dimeric alkaloids with α-tubulin: a molecular docking study
Gérard Vergoten, Christian Bailly
(2024), pp. 277-291
Open Access
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
Damilola Oluwalana, Kelli L. Adeleye, Raisa I. Krutilina, et al.
Cancer Letters (2024) Vol. 597, pp. 217011-217011
Open Access
Tubulin-Targeted Therapy in Melanoma Increases Cell Invasive Potential by Activation of Actomyosin Cytoskeleton - an in vitro study
Marcin Luty, Renata Szydlak, Joanna Pabijan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
Jean Guillon, Solène Savrimoutou, Sandra Albenque-Rubio, et al.
Molbank (2023) Vol. 2023, Iss. 3, pp. M1691-M1691
Open Access | Times Cited: 1
Design, synthesis and evaluation of dihydro-1 H -indene derivatives as novel tubulin polymerisation inhibitors with anti-angiogenic and antitumor potency
Shengtao Xu, Yijun Sun, Peng Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Page 1

Scroll to top